Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Revivo Therapeutics
Durham, North Carolina, United Statesrevivotherapeutics.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Revivo is conducting Phase I clinical trials with its lead candidate RIV‑5061 in healthy volunteers to assess safety, tolerability, pharmacokinetics/pharmacodynamics. The drug acutely enhances cognitive function and reduces anxiety in preclinical models. The company is raising funds for further clinical development.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small molecules (specifically nomethiazoles, nitric oxide donor prodrugs, GABA(A) positive allosteric modulators)
- Industry
- Biotech
02
Partnerships
NIHADDF (Alzheimer's Drug Discovery Foundation)Bioventures Investors have provided funding support.
Beyond the preview
Go deeper on Revivo Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Revivo Therapeutics.